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ABSTRACT
Background: Dietary flavonoids may protect against cardiovas-
cular disease, but evidence is still conflicting. Tea is the major
source of flavonoids in Western populations.
Objective: The association of tea and flavonoid intake with inci-
dent myocardial infarction was examined in the general Dutch
population.
Design: A longitudinal analysis was performed with the use of
data from the Rotterdam Study—a population-based study of
men and women aged ≥ 55 y. Diet was assessed at baseline
(1990–1993) with a validated semiquantitative food-frequency
questionnaire. The analysis included 4807 subjects with no his-
tory of myocardial infarction, who were followed until 31 Decem-
ber 1997. Data were analyzed in a Cox regression model, with
adjustment for age, sex, body mass index, smoking status, pack-
years of cigarette smoking, education level, and daily intakes of
alcohol, coffee, polyunsaturated fat, saturated fat, fiber, vitamin E,
and total energy.
Results: During 5.6 y of follow-up, a total of 146 first myocar-
dial infarctions occurred, 30 of which were fatal. The relative
risk (RR) of incident myocardial infarction was lower in tea drinkers
with a daily intake > 375 mL (RR: 0.57; 95% CI: 0.33, 0.98) than
in nontea drinkers. The inverse association with tea drinking
was stronger for fatal events (0.30; 0.09, 0.94) than for nonfatal
events (0.68; 0.37, 1.26). The intake of dietary flavonoids
(quercetin + kaempferol + myricetin) was significantly inversely
associated only with fatal myocardial infarction (0.35; 0.13, 0.98)
in upper compared with lower tertiles of intake.
Conclusions: An increased intake of tea and flavonoids may
contribute to the primary prevention of ischemic heart disease.
Am J Clin Nutr 2002;75:880–6.
KEY WORDS Tea, flavonoids, myocardial infarction, ischemic
heart disease, population-based study, the Rotterdam Study,
Netherlands
INTRODUCTION
Epidemiologic studies have reported a reduced risk of
ischemic heart disease in subjects with a high flavonoid intake
through tea and other dietary sources (1–3), but findings are still
conflicting (4, 5). The potential protective effect of flavonoids
has been attributed to antioxidant (6–11), antithrombogenic
(12–14), and antiinflammatory (15, 16) properties. Recent ani-
mal experiments suggest that flavonoids may also improve vas-
cular function (17–19). In a previous cross-sectional analysis of
data from the Rotterdam Study, we observed an inverse associa-
tion of tea intake with aortic atherosclerosis (20). The present
longitudinal study addresses the relation between tea intake and
risk of first incident myocardial infarction in this population-
based cohort of men and women aged ≥ 55 y.
SUBJECTS AND METHODS
The Rotterdam Study
The Rotterdam Study is a prospective study to assess the
occurrence of chronic diseases in an aging population and to
clarify the determinants of the diseases (21). The cohort com-
prises 7983 men and women aged ≥ 55 y (78% of the eligible
population) who live in a defined district of Rotterdam. From
August 1990 until June 1993, baseline data on current and past
health, medication use, and risk indicators for chronic diseases
were collected during a home interview by a trained research
assistant. The participants were subsequently invited to the study
center for a clinical examination and an assessment of diet.
Clinical examination
Height and weight were measured while the subjects were
wearing indoor clothing and no shoes. Body mass index was com-
puted as weight (in kg) divided by height squared (in m). Sitting
systolic and diastolic blood pressures were measured twice with a
random-zero sphygmomanometer by a trained research assistant
after the subjects had rested for 5 min. The mean of the 2 blood
pressure measurements was used in the analysis. A standard elec-
trocardiogram was obtained, which was interpreted by using
MEANS (Modular ECG Analysis System; 22). The subjects were
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considered to have diabetes mellitus if they reported using antidi-
abetes medication or if their nonfasting random or postload blood
glucose concentrations were ≥11.1 mmol/L. Serum total choles-
terol concentrations (mmol/L) were measured with the use of an
automated enzymatic procedure (23). HDL cholesterol was meas-
ured similarly, after precipitation of the non-HDL fraction.
Dietary assessment
The participants indicated on a checklist all of the foods and
beverages that they consumed more than once a month during the
preceding year. The completed checklist formed the basis of an
interview at the study center by a trained dietitian, who used a
validated, semiquantitative food-frequency questionnaire (24). In
two-thirds of the dietary interviews, a computerized version of the
questionnaire was used, which included data checks. Participants
quantified their habitual tea intake as the number of cups ingested
per day, week, or month. One cup of tea was considered to equal
125 mL. Only the intake of black tea was assessed because this
type of tea is predominantly consumed in the Netherlands. Intakes
of total energy, macronutrients, and a large number of micronutri-
ents were calculated from the food data with the use of Dutch
food-composition tables (25). The total intake (mg/d) of the
flavonols quercetin, kaempferol, and myricetin was computed
with the use of published tables by Hertog et al (26, 27). Tea is a
major source of flavonoids, <10% of which are flavonols (28, 29).
Follow-up procedures
The present analysis is based on follow-up data collected from
baseline (1990–1993) until 31 December 1997. Information on
the vital status of the participants was obtained at regular inter-
vals from the municipal population registry. Informed consent for
collection of follow-up data from the participants’ general practi-
tioners was obtained for 7751 participants of the Rotterdam
Study (97%). Fatal and nonfatal events were reported by the gen-
eral practitioners in the research area (covering 85% of the cohort)
by means of a computerized system. All reported events were ver-
ified by research physicians who collected information from the
patients’ medical records at the general practitioners’ offices. The
information also included copies of discharge letters for hospital
admissions of interest. The fatal and nonfatal events were coded
independently by 2 research physicians according to the Interna-
tional Statistical Classification of Diseases and Related Health
Problems, 10th revision (ICD-10) (30). If there was disagreement
between reviewers, consensus was reached in a separate session. A
medical expert in the field subsequently reviewed the coded events
and his or her decision was considered definite if there were dis-
crepancies. Myocardial infarctions included fatal and nonfatal
incident events with an ICD-10 code I21. In the case of recurrent
myocardial infarctions during follow-up, the first event was used
in the analysis. A myocardial infarction was considered fatal if
death occurred within 28 d after the onset of symptoms.
Study population
A total of 6521 independently living subjects attended the
study center at baseline (82% of the Rotterdam Study cohort) and
were eligible for a dietary interview. Diet could not be assessed
in 271 participants of the pilot phase of the Rotterdam Study.
Additionally, 122 subjects suspected of dementia were not inter-
viewed because of expected difficulties in dietary recall, nor
were a random group of 481 subjects because of logistic reasons.
The dietitian considered 212 dietary reports unreliable, which
were ultimately excluded. Dietary data were thus available for
5435 subjects, who had given informed consent for collection of
follow-up data. We excluded 628 subjects with a self-reported
history of myocardial infarction, which was verified with an elec-
trocardiogram, who might intentionally have changed their diet.
Thus, a total of 4807 subjects comprised the present analysis.
Data analysis
Data were analyzed by using SPSS version 10.0.5 for WINDOWS
(SPSS Inc, Chicago). Age- and sex-adjusted partial correlations
of tea and flavonoid intakes with lifestyle factors and nutrient
intakes were computed to identify potential confounders.
The risk of myocardial infarction with tea intake was estimated
by Cox regression analysis with adjustment for age and sex.
Associations were obtained separately for total, nonfatal, and fatal
myocardial infarction. Survival time was calculated as the num-
ber of days from entry into the study until the time of the first
myocardial infarction, the time until death, or until 31 December
1997, whichever came first. Tea intake was first entered continu-
ously into the survival model, forcing a linear relation. Subse-
quently, tea intake was classified on the basis of the frequency
distribution of the variable, yielding categories of 0 mL (refer-
ence), 1–375 mL (median: 250 mL), and >375 mL (median:
500 mL). The relative risks (RRs) and 95% CIs were obtained by
category of tea intake. The same procedure was followed to cal-
culate RRs in tertiles of flavonoid intake (total of quercetin,
kaempferol, and myricetin intakes); the RR of a first myocardial
infarction was calculated according to 3 categories of flavonoid
intake: <22.8, 22.8–32.9, and >32.9 mg/d.
The analyses of tea and flavonoid intakes were repeated in a
multivariate model adjusted for age, sex, body mass index, smok-
ing status (current, former, never), pack-years of cigarette smok-
ing (ie, the average number of packs of cigarettes smoked per
day  the number of years smoked) for current and former smokers,
education level [low (primary education), intermediate (secondary
general or vocational education), or high (higher vocational edu-
cation, university)], and daily intakes of alcohol (0, >0–5, >5–10,
>10–20, and >20 g/d), coffee (mL), polyunsaturated fat (g), sat-
urated fat (g), fiber (g), vitamin E (mg), and total energy (kJ).
Stratified analyses were performed according to sex. Data were
also analyzed separately for current, former, and never smokers to
examine in more detail the role of confounding by smoking. In
addition, the interaction of tea or flavonoid intake with smoking
in determining the risk of myocardial infarction was examined by
adding interaction terms to the model.
The possibility that preexisting illness, which could be related
to dietary changes, influenced the risk estimates was examined in
an analysis in which data from the first year of follow-up were dis-
carded for all subjects. A total of 52 subjects with an early
myocardial infarction were not included in this analysis. Finally,
we investigated whether serum HDL or total cholesterol could be
intermediary factors in the relation of tea intake with cardiac
events by adding these variables to the survival model and exam-
ining the changes in risk estimates. Similarly, potential intermedi-
ary roles of blood pressure and diabetes mellitus were examined.
RESULTS
The study population comprised 1836 men and 2971 women
with a mean (± SD) age of 67.4 ± 7.8 y; 84% of the men and 90%
of the women were tea drinkers. The mean daily intake of tea in
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the total population was 371 ± 257 mL, or 3 cups. The mean
intake of flavonoids was 28.6 ± 12.3 mg/d. The general charac-
teristics of the study population by categories of tea intake are
presented in Table 1. After adjustment for age and sex, tea intake
was significantly inversely associated with body mass index,
smoking status, and serum total cholesterol and significantly
positively associated with education level.
The dietary intakes of the participants are shown in Table 2 by
categories of tea intake. A significant association of tea with all
dietary intakes was observed after adjustment for age, sex, and
total energy. Intakes of flavonoids and tea were strongly corre-
lated (r = 0.81, P < 0.001). The proportions of tea drinkers in
consecutive tertiles of flavonoid intake (< 22.8, 22.8–32.9, and
> 32.9 mg/d) were 69%, 95%, and 99%, respectively.
The study had a mean follow-up of 5.6 ± 1.3 y and consisted
of 26 733 person-years. The incidence of myocardial infarction
was 8.3/1000 person-years in men (n = 1836 persons and
84 events) and 3.7/1000 person-years in women (n = 2971 per-
sons and 62 events) free of myocardial infarction at baseline.
Thirty subjects experienced a fatal myocardial infarction and
475 subjects died from other causes during follow-up. In the
study of the age- and sex-adjusted linear association of tea drink-
ing with incidence of myocardial infarction, a 8.2% risk reduc-
tion was observed per 100-mL increase in tea intake (P = 0.02;
data not shown). After adjustment for body mass index, smoking
status, alcohol intake, education level, and dietary factors, the
association was attenuated to a 6.2% risk reduction per 100-mL
increase in tea intake (P = 0.09).
The RRs of a first myocardial infarction by categories of tea
intake are shown in Table 3. The incidence of myocardial infarc-
tion was inversely associated with tea intake after adjustment for
age and sex; the RR was 0.51 (95% CI: 0.30, 0.84) for intakes
>375 mL/d (3 cups/d) compared with an intake of 0 mL/d.
After additional adjustment for body mass index, smoking status,
pack-years of cigarette smoking, education level, and daily intakes
of alcohol, coffee, polyunsaturated fat, saturated fat, fiber, vita-
min E, and total energy, the association of tea intake with all inci-
dent myocardial infarctions was attenuated in the upper category
of tea intake (RR: 0.57; 95% CI: 0.33, 0.98). Further adjustment
for dietary intakes of riboflavin (mg/d), vitamin B-6 (mg/d), vita-
min C (mg/d), -carotene (mg/d), bread (g/d), vegetables (g/d),
and fruit (g/d) did not change the results. Tea drinking was related
both to nonfatal and to fatal myocardial infarctions, but only the
association with fatal events in the upper category of tea intake
was significant (RR: 0.30; 95% CI: 0.09, 0.94).
The RRs of a myocardial infarction (fatal or nonfatal) by tea
intake were no longer significant when the analysis was stratified
by sex. In women, the RR was 0.71 (95% CI: 0.32, 1.60) for
intakes ≤ 375 mL/d and was 0.46 (95% CI: 0.19, 1.10) for intakes
> 375 mL/d. In men, the RR was 0.76 (95% CI: 0.41, 1.40) for
intakes ≤ 375 mL/d and was 0.61 (95% CI: 0.30, 1.26) for intakes
> 375 mL/d, but the interaction term of tea and sex was not signi-
ficant. The inverse association of tea drinking with myocardial
infarction was more pronounced in current smokers [n = 1114
and 38 events; RR of 0.58 (95% CI: 0.27, 1.24) and 0.47 (0.17,
1.47)] than in former smokers [n = 2000 and 72 events; RR of
0.74 (0.35, 1.56) and 0.50 (0.22, 1.14)] or never smokers
[n = 1693 and 36 events; RR of 1.22 (0.28, 5.33) and 0.87 (0.19,
3.95)] in the mid and upper categories of tea intake, respectively.
The interaction term for tea intake and smoking status was not
significant in the multivariate model. The reduction in risk of
myocardial infarction with increasing tea intake remained essen-
tially unchanged after the exclusion of data for 52 subjects who
had a myocardial infarction or who died within 1 y of follow-up
[multivariate RR: 0.77 (0.45, 1.30) and 0.59 (0.33, 1.06) in the
mid and upper categories of tea intake, respectively].
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TABLE 1
General characteristics of 4807 Dutch participants in the Rotterdam Study, by categories of tea intake
Tea intake
0 mL/d 1–375 mL/d >375 mL/d
(n = 583) (n = 2340) (n = 1884) Unadjusted P1
Men (%) 50.4 42.7 29.0 <0.001
Age (y) 64.2 ± 6.72 66.7 ± 7.1 69.2 ± 7.7 <0.001
BMI (kg/m2) 26.5 ± 3.9 26.3 ± 3.4 26.2 ± 3.7 0.15
Smoking status (%) <0.001
Current 46.6 23.9 15.4
Former 35.8 43.2 40.7
Never 17.6 32.9 44.0
Educational level (%)3 0.024
Low 32.7 34.7 34.2
Intermediate 51.1 54.0 54.9
High 16.2 11.3 10.9
Blood pressure (mm Hg)
Systolic 135.1 ± 20.2 138.3 ± 22.5 140.0 ± 21.9 <0.001
Diastolic 74.5 ± 10.9 74.1 ± 11.2 73.1 ± 11.3 0.005
Serum cholesterol (mmol/L)
Total 6.7 ± 1.2 6.7 ± 1.2 6.6 ± 1.2 0.082
HDL 1.4 ± 0.3 1.4 ± 0.4 1.4 ± 0.4 0.045
Diabetes mellitus 8.7 8.3 9.0 0.71
1 Unadjusted P value for linear trend test (continuous variables) or P value from chi-square test (discrete variables). After adjustment for age and sex, tea
intake was significantly inversely associated with BMI, smoking status, and serum total cholesterol, and significantly positively associated with education level.
2 x– ± SD.
3 Low, primary education; intermediate, secondary general or vocational education; high, higher vocational education, university.
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Dietary flavonoids were nearly significantly related to the risk
of myocardial infarction, with a 12.7% reduction in risk per
10-mg increase in daily flavonoid intake after adjustment for
age and sex (P = 0.07; data not shown). Further adjustment for
confounders attenuated the risk reduction to 9.0% per 10-mg
increase in flavonoid intake, which was no longer significant.
The RRs of myocardial infarction by tertiles of flavonoid intake
are shown in Table 4. For all incident cases of myocardial infarc-
tion, a nonsignificant inverse association was observed in the
middle (RR: 0.74; 95% CI: 0.49, 1.11) and upper (RR: 0.76; 95%
CI: 0.49, 1.18) tertiles of flavonoid intake. In a separate analysis
of the risk of nonfatal and fatal myocardial infarctions in relation
to flavonoid intake, a nearly significant association, was
observed only for fatal events in a comparison of the middle
(RR: 0.42; 95% CI: 0.17, 1.06) and upper (RR: 0.35; 95% CI:
0.13, 0.98) tertiles with the lower tertile.
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TABLE 3
Relative risk (RR) of a first myocardial infarction in 4807 Dutch participants in the Rotterdam Study, by categories of tea intake
Tea intake
0 mL/d 1–375 mL/d >375 mL/d
Median tea intake (mL/d) 0.0 250.0 500.0
Number of subjects 583 2340 1884
Follow-up time (person-years) 3277 12990 10588
All incident myocardial infarctions
Number of events 24 77 45
RR, age- and sex-adjusted model 1 0.72 (0.49, 1.13)1 0.51 (0.30, 0.84)
RR, multivariate model2 1 0.77 (0.48, 1.25) 0.57 (0.33, 0.98)
Nonfatal myocardial infarctions
Number of events 18 61 57
RR, age- and sex-adjusted model 1 0.80 (0.47, 1.36) 0.62 (0.35, 1.11)
RR, multivariate model2 1 0.84 (0.49, 1.47) 0.68 (0.37, 1.26)
Fatal myocardial infarction
Number of events 6 16 8
RR, age- and sex-adjusted model 1 0.47 (0.18, 1.23) 0.24 (0.08, 0.72)
RR, multivariate model2 1 0.58 (0.22, 1.57) 0.30 (0.09, 0.94)
1 95% CI in parentheses. Values obtained with a Cox proportional hazards analysis.
2 Model adjusted for age, sex, BMI, smoking status, pack-years of cigarette smoking, education level, and daily intakes of alcohol, coffee, polyunsatu-
rated fat, saturated fat, fiber, vitamin E, and total energy.
TABLE 2
Daily dietary intakes of 4807 Dutch participants in the Rotterdam Study, by categories of tea intake
Tea intake
0 mL/d 1–375 mL/d >375 mL/d
(n = 583) (n = 2340) (n = 1884) Unadjusted P1
Median tea intake (mL) 0.0 250.0 500.0
Alcohol intake
(%) 82.8 80.3 77.9 <0.001
(g)2 19.3 ± 22.33 13.2 ± 15.7 10.2 ± 12.8 <0.001
Coffee intake
(%) 98.5 98.2 95.4 <0.001
(mL)4 655.9 ± 309.0 497.4 ± 208.2 439.9 ± 188.2 <0.001
Dietary intake
Total energy (kJ/d) 8335 ± 2435 8281 ± 2125 8171 ± 1955 0.047
Riboflavin (mg/d) 1.64 ± 0.61 1.56 ± 0.54 1.52 ± 0.47 <0.001
Vitamin B-6 (mg/d) 1.56 ± 0.46 1.56 ± 0.41 1.61 ± 0.37 <0.001
Vitamin C (mg/d) 115.3 ± 53.8 119.2 ± 54.2 124.1 ± 53.6 <0.001
Vitamin E (mg/d) 13.1 ± 5.8 13.8 ± 6.3 13.9 ± 6.0 0.033
Flavonoids (mg/d)5 14.8 ± 8.1 24.1 ± 7.9 38.5 ± 10.2 <0.001
-Carotene (mg/d) 1.56 ± 1.01 1.50 ± 0.65 1.56 ± 0.76 0.30
Fiber (g/d) 16.5 ± 5.8 16.6 ± 5.0 17.0 ± 5.0 0.006
Polyunsaturated fat (g/d) 15.0 ± 7.7 15.3 ± 7.8 15.0 ± 11.3 0.38
Saturated fat (g/d) 32.4 ± 12.9 32.1 ± 11.8 31.5 ± 7.6 0.12
Total fat (g/d) 81.8 ± 30.1 81.1 ± 27.5 79.3 ± 26.0 0.019
1 Unadjusted P value for linear trend (continuous variables) or P value from chi-square test (discrete variables). After adjustment for age, sex, and total
energy intake, tea intake was significantly positively associated with intakes of vitamin B-6, vitamin C, vitamin E, flavonoids, -carotene, fiber, polyunsat-
urated fat and significantly inversely associated with intakes of riboflavin, alcohol, coffee, saturated fat, and total fat.
2 Computation includes data only from subjects who drank alcohol.
3 x– ± SD.
4 Computation includes data only from subjects who drank coffee.
5 Total of quercetin, kaempferol, and myricetin.
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An inverse relation of dietary flavonoid intake with incident
myocardial infarction was observed in women in the middle
(RR: 0.53; 95% CI: 0.28, 1.00) and upper (RR: 0.59; 95% CI:
0.31, 1.14) tertiles of intake, which was nearly significant. In
men, however, dietary flavonoid intake was not associated with
incident myocardial infarction in the middle (RR: 0.92; 95% CI:
0.54, 1.56) and upper (0.95; 95% CI: 0.52, 1.76) tertiles. The
interaction term for flavonoid intake and sex was not significant
in the multivariate model. A subgroup analysis according to
smoking status yielded nonsignificantly different RRs of
myocardial infarction by flavonoid intake (data not shown).
A repeat of the analyses of tea and flavonoid intakes after
adjustment for serum HDL and total cholesterol, systolic and
diastolic blood pressures, or diabetes mellitus did not change the
results significantly, indicating no strong intermediary roles for
these indexes.
DISCUSSION
We observed significant inverse associations of tea and
flavonoid intakes with incident myocardial infarction in the gen-
eral Dutch population. The reductions in risk were strongest for
fatal events.
Tea drinking in Western populations is generally associated with
a healthy lifestyle and diet. In the present study, tea intake was
higher in lean, educated people who smoked less and consumed a
relatively healthy diet. The risk reductions for myocardial infarc-
tion were attenuated after adjustment for lifestyle and dietary con-
founders, which indicates that diet and lifestyle explain part of the
protective effect of tea. Although the observed associations were
strong, residual confounding could not be excluded. Smoking was
associated with tea and flavonoid intakes and is a strong risk factor
for myocardial infarction. The association of tea intake, but not of
flavonoid intake, with myocardial infarction was weaker in non-
smokers than in smokers. This finding suggests that smoking,
despite adjustment for smoking status and pack-years of cigarette
smoking, caused some residual confounding of the risk estimates.
An alternative explanation for the differences in RRs between
smokers and nonsmokers is that smokers have a greater need for
flavonoids (and other antioxidants) because of the vascular damage
caused by smoking. The study lacked the power to examine sepa-
rately the risk of fatal myocardial infarction with tea intake in cat-
egories of smoking.
Unfortunately, data on physical activity were not collected
during the baseline survey of the Rotterdam Study; therefore,
we could not adjust for it. However, we adjusted for total
energy intake, which is closely related to energy expenditure, and
lifestyle factors such as smoking and alcohol intake. Adjustment
for these correlates of physical activity removed some of the con-
founding, but it is possible that residual confounding remained.
Serum HDL-cholesterol, which is favorably affected by physical
activity (31), did not differ significantly by categories of tea
intake after adjustment for age and sex. Therefore, we believe that
physical activity was not a strong confounder in our cohort.
Prevalent illness should be taken into account when studying the
effect of diet on incident disease or mortality because dietary
changes resulting from clinical or subclinical disease could lead
to biased risk estimates. For this reason, we excluded subjects
with a history of myocardial infarction at baseline. Additional
exclusion of subjects with a nonfatal myocardial infarction or
fatal event within 1 y of follow-up yielded nonsignificantly dif-
ferent risk estimates.
Flavonoids have been shown to protect against the oxida-
tion of LDL in vitro, to inhibit platelet aggregation, to reduce
inflammatory processes, and to improve vascular function (6–17).
Black tea contains substantial concentrations of the flavonols
quercetin (10–25 mg/L), kaempferol (7–17 mg/L), and myricetin
(2–5 mg/L) (26). Regrettably, we could not examine the poten-
tial cardioprotective effect of catechins and polyphenols, which
are also abundant in tea (28, 29). In men in the Zutphen Elderly
Study, tea drinkers had a risk of 5-y mortality from ischemic
heart disease that was >50% lower than that of nontea drinkers (1),
which is comparable with our findings. No association between
tea intake and ischemic heart disease was observed in the Health
Professionals Follow-up Study of men, who were on average 10 y
younger than our study participants (4). Tea accounted for 25%
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TABLE 4
Relative risk (RR) of a first myocardial infarction in 4807 Dutch participants in the Rotterdam Study, by tertiles of flavonoid intake
Tertile of flavonoid intake
Lower (<22.8 mg/d) Middle (22.8–32.9 mg/d) Upper (>32.9 mg/d)
Median flavonoid intake (mg/d) 16.8 27.5 40.0
Number of subjects 1602 1603 1602
Follow-up time (person-years) 8851 8909 8973
All incident myocardial infarctions
Number of events 62 43 41
RR, age- and sex-adjusted model 1 0.69 (0.47, 1.02)1 0.68 (0.46, 1.02)
RR, multivariate model2 1 0.74 (0.49, 1.11) 0.76 (0.49, 1.18)
Nonfatal myocardial infarctions
Number of events 45 36 35
RR, age- and sex-adjusted model 1 0.81 (0.52, 1.26) 0.83 (0.53, 1.30)
RR, multivariate model2 1 0.85 (0.54, 1.34) 0.93 (0.57, 1.52)
Fatal myocardial infarction
Number of events 17 7 6
RR, age- and sex-adjusted model 1 0.38 (0.16, 0.93) 0.33 (0.13, 0.83)
RR, multivariate model2 1 0.42 (0.17, 1.06) 0.35 (0.13, 0.98)
1 95% CI in parentheses. Values obtained with a Cox proportional hazards analysis.
2 Model adjusted for age, sex, BMI, smoking status, pack-years of cigarette smoking, education level, and daily intakes of alcohol, coffee, polyunsatu-
rated fat, saturated fat, fiber, vitamin E, and total energy.
 at Swets Subscription Service 76130274 on Novem









of the flavonoid intake in the Health Professionals Study,
whereas tea intake accounted for > 50% of the flavonoid intake
in our study. In the Caerphilly Study of Welsh men aged 45–79 y,
no protective effect of tea against ischemic heart disease was
observed (5). It was later suggested that residual confounding
by socioeconomic status blurred the association of tea with
ischemic heart disease in the Caerphilly Study (32).
Tea and flavonoid intakes were predominantly related to fatal
myocardial infarctions; the relation with nonfatal events was weak
or absent in our study. Also, in the Zutphen Elderly Study the RR
of mortality from ischemic heart disease was stronger than that
of incident myocardial infarction, which included nonfatal
events (1). The Finnish study by Knekt et al (2) showed strongly
reduced risks of mortality from ischemic heart disease in sub-
jects with a high flavonoid intake. However, no such relation
was observed in the Health Professionals Study, in which non-
fatal myocardial infarction was the outcome of interest (4).
Possibly, subjects with a fatal event had more severe athero-
sclerosis than did those with no fatal event. In the cohort of the
Rotterdam Study, we showed a strong inverse association of tea
intake with severe aortic calcification, whereas no association
with mild atherosclerosis was observed (20). Our findings sug-
gest that the severity of underlying cardiovascular disease may
modify the relation of flavonoids with coronary events. It is also
possible that flavonoids (together with other antioxidants)
reduce oxidative stress and prevent excess damage after
ischemia, thereby increasing the chance of recovery from a
myocardial infarction. Furthermore, flavonoids could be involved
in thrombotic processes that may influence the severity of a coro-
nary event (13, 14). Unfortunately, we cannot conclude from our
observational data which of the above mechanisms, if any,
accounted for the discrepant findings on fatal and nonfatal
myocardial infarctions.
In our previous study of the relation between tea intake and
aortic atherosclerosis in the Rotterdam Study, we observed a
strong inverse relation in women (20). In the present study we
observed a strong inverse relation between tea intake and inci-
dent myocardial infarction, and the relation was stronger in
women than in men. For flavonoid intake, a strong relation with
incident myocardial infarction was observed only in women,
which raises the hypothesis that flavonoids act not only as
antioxidants or antithrombogenic factors but possibly also as
phytoestrogens. An estrogenic effect of kaempferol, present in
tea, was shown previously in vitro (33). In the female partici-
pants of the Rotterdam Study, we found a positive association
of tea drinking with prolactin secretion, which was used as a
bioassay of estrogenic activity (34). Another study in women
showed a positive association of tea intake with bone mineral
density, which is known to be strongly influenced by estrogenic
activity (35). The structure of flavonoids shows similarities to
that of isoflavones in soy (33, 36), for which beneficial cardio-
vascular actions have been reported (37). However, the
flavonoids in tea are less potent estrogenic compounds than are
isoflavones in vitro. More research is needed to assess whether
the estrogenic activity of tea is biologically important to the
human body.
In conclusion, our findings suggest a protective effect of tea
and flavonoid intakes against myocardial infarction. The under-
lying biological mechanisms for this effect and the potential role
of tea flavonoids in cardiovascular disease prevention deserve
further study.
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